HIGHLIGHTS
- who: Chuan-Chien Yang et al. from the Department of Otolaryngology, Da Cancer Hospital, Kaohsiung, Taiwan have published the research work: Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa, in the Journal: Cancers 2022, 2022,14, 14, xx Cancers of 17/04/2022
- what: This study was approved by the E-Da Hospital Institutional Review Board (EMPR-110-167) and was conducted in accordance with the Declaration of Helsinki. At the end of the study , 52% of the patients died and cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.